by Laurie McGinley | Jun 23, 2016 | Health
The Washington Post By Laurie McGinley A National Institutes of Health advisory panel has approved the first human use of the gene-editing technology CRISPR, for a study designed to target three types of cancer and funded by tech billionaire Sean Parker’s new...
